Intoxication with Riluzole in Huntington's Diease
Neurol 57:1141-1143, Bodner,Th.,et al, 2001
Protocol Violations in Community-Based rTPA Stroke Treatment Are Associated with Symptomatic Intracerebral Hemorrhage
Stroke 32:12-16, Lopez-Yunez,A.M.,et al, 2001
Weight Change Associated with Valproate and Lamotrigine Monotherapy in Patients with Epilepsy
Neurol 56:172-177, Biton,V.,et al, 2001
Neuropsychological Effects of Epilepsy and Antiepileptic Drugs
Lancet 357:216-222, Kwan,P. &Brodie,M.J., 2001
Risk Factors for Sever Hemorrhagic Transformation in Ischemic Stroke Patients Treated with Recombinant Tissue Plasminogen Activator
Stroke 32:438-441, Larrue,V.,et al, 2001
Vaccinations and the Risk of Relapse in Multiple Sclerosis
NEJM 344:319-326,372, Confavreux,C.,et al, 2001
Systematic Review of Long Term Anticoagulation or Antiplatelet Treatment in Patients with Non-rheumatic Atrial Fibrillation
BMJ 322:321-326, Taylor,F.C.,et al, 2001
Rapid Initiation of Gabapentin, A Randomized, Controlled Trial
Neurol 56:743-748, Fisher,R.S.,et al, 2001
Phenylpropanolamine and Hemorrhagic Stroke
NEJM 344:1094-1095, Ernst,M.E.,et al, 2001
Confusion After Antibiotics
Lancet 357:1410, Gavazzi,C.,et al, 2001
Intracranial Hemorrhages Associated with Sumatriptan
Neurol 56:1243-1244, Combremont,P.C. & Marcus,E.M., 2001
Differential Cognitive and Behavioral Effects of Carbamazepine and lamotrigine
Neurol 56:1177-1182, Meador, K.J.,et al, 2001
Dietary Supplements Containing Ephedra Alkalokds
NEJM 344:1095-1097, Hutchins,G.M.,et al, 2001
Intraspinal Steroids: History, Efficacy, Accidentality, and Controversy with Review of United States Food and Drug Administration Reports
JNNP 70:433-443, Nelson,D.A. & Landau,W.M., 2001
The Teratogenicity of Anticonvulsant Drugs
NEJM 344:1132-1138, Holmes,L.B.,et al, 2001
Safety of Diastat When Given at Larger-than-recommended Doses for Acute Repetitive Seizures
Neurol 56:1112, Brown,L.,et al, 2001
Cerebral Sinus Thrombosis with Tamoxifen
Neurol 56:1113-1114, Finelli,P.F. & Schauer,P.K., 2001
Benign Intracranial Hypertension Secondary to Nasal Fluticasone Propionate
BMJ 322:897, Bond,D.W.,et al, 2001
Safety of HMG-CoA Reductase Inhibitors: Focus on Atorvastatin
Cardiovasc Drugs Ther 15:211-218, Bernini,F.,et al, 2001
Gemcitabine-Associated Posterior Reversible Encephalopathy Syndrome: MR Imaging and MR Spectroscopy Findings
Magnetic Resonance Imaging 19:129-132, Russell,M.T,et al, 2001
Onset of Multiple Sclerosis Associated With Anti-TNF Therapy
Neurol 57:1885-1888, Sicotte,N.L. &Voskuhl,R.R., 2001
Eosinophilic Fasciitis and Simvastatin
Arch Int Med 161:1456-1457, Choquet-Kastylevsky,G.,et al, 2001
Uveal Effusion and Secondary Angle-Closure Glaucoma Associated with Topiramate Use
Arch Ophthalmol 119:1210-1211, Sankar,P.S., 2001
The Expanding Spectrum of Herpesvirus Infections of the Nervous System
Brain Pathol 11:440-451, Kleinschmidt-DeMasters,B.K. &Gilden,D.H., 2001
Caudate Hemorrhage as a Possible Complication of Midodrine-Induced Supine Hypertension
Mayo Clin Proc 76:1275, Sandroni, P.,et al, 2001
Adverse Effects of Antiretroviral Therapy
Lancet 356:1423-1430, Carr,A. &Cooper, D.A., 2000
Psychiatric Emergencies, The Neuroleptic Malignant and Serotonin Syndromes
Emerg Med Clin North Am 18:317-325, Carbone,J.R., 2000
A 5-Month, Randomized, Placebo-controlled Trial of Galantamine in AD
Neurol 54:2269-2276, Tariot,P.N.,et al, 2000
Galantamine in AD
Neurol 54:2261-2268, Raskind,M.A.,et al, 2000
Orolingual Angioneurotic Edema Following Therapy of Acute Ischemic Stroke with Alteplase
Neurol 55:599-600, Rudolf,J. et al, 2000
Acute Orhtostatic Hypotension When Starting Dopamine Agonists in Parkinson's Disease
Arch Neurol 57:1461-1463, Kujawa,K.,et al, 2000
Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease
JAMA 284:1931-1938,1971, Parkinson Study Group, 2000
Folic Acid Antagonists During Pregnancy and the Risk of Birth Defects
NEJM 343:1608-1614, Hernandez-Dias,S.,et al, 2000
Safety of Discontinuation of Anticoagulation in Patients with Intracranial Hemorrhage at High Thromboembolic Risk
Arch Neurol 57:1710-1713,1682, Phan,T.G.,et al, 2000
Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra Alkaloids
NEJM 343:1833-1838,1886, Haller,C.A. & Benowitz,N.L., 2000
Phenylpropanolamine and the Risk of Hemorrhagic Stroke
NEJM 343:1826-1832,1886, Kernan,W.N.,et al, 2000
Zonisamide (Zonegran) for Epilepsy
The Medical Letter 42:94-95, , 2000
Rivastigmine (Exelon) for Alzheimer's Disease
The Medical Letter 42:93-94, , 2000
Treatment of Drug-Induced Psychosis with Quetiapine and Clozapine in Parkinson's Disease
Neurol 55:1753-1754, Dewey,R.B.Jr. & O'Suilleabhain,P.E., 2000
Safety of Pramipexole in Patients with Restless Legs Syndrome
Neurol 55:1589-1590, Stiasny,K.,et al, 2000
Protein C Deficiency Related to Valproic Acid Therapy: A Possible Association with Childhood Stroke
J Pediatr 137:714-718, Gruppo,R.,et al, 2000
Selegiiline and Mortality in Subjects with Parkinson's Disease
Neurol 55:1785-1789,1770, Donnan,P.T.,et al, 2000
Superior Sagittal Sinus Thrombosis Due to Lithium:Local Urokinase Thrombolysis Treatment
Neurol 54:532-533, Wasay,M.,et al, 2000
Treating Acute Stroke Patients with Intravenous tPA, The OSF Stroke Network Experience
Stroke 31:77-81, Wang,D.Z.,et al, 2000
Donepezil Therapy in Clinical Practice, A Randomized Crossover Study
Arch Neurol 57:94-99, Greenberg,S.M.,et al, 2000
Cerebral Venous Thrombosis Associated with Epoetin Alfa Therapy
Arch Neurol 57:260-262, Finelli,P.F.&Carley,M.D., 2000
Tolcapone and Hepatotoxic Effects
Arch Neurol 57:263-267, Olanow,C.W.&Tasmar Advisory Panel, 2000
Valproate-Induced Hyperammonemic Encephalopathy in the Presence of Topiramate
Neurol 54:230-232, Hamer,H.M.,et al, 2000
Aspirin for the Primary Prevention of Stroke and Other Major Vascular Events
ArchNeurol 57:326-332,306, Hart,R.G.,et al, 2000
Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
JAMA 283:1145-1150,1189, Albers,G.W.,et al, 2000